Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A42488 | 34400107 | Dig Liver Dis | Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A42489 | 34399043 | Ultrasonography | Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: a systematic review and meta-analysis of prospective studies. | 2021 | Details |
| A42490 | 34391717 | Am J Pathol | This Month in AJP. | 2021 | Details |
| A42491 | 34390271 | Semin Dial | The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients. | 2021 | Details |
| A42492 | 34387552 | JMIR Med Inform | Current-Visit and Next-Visit Prediction for Fatty Liver Disease With a Large-Scale Dataset: Model Development and Performance Comparison. | 2021 | Details |
| A42493 | 34386201 | Clin Liver Dis (Hoboken) | Artificial Intelligence in Nonalcoholic Fatty Liver Disease: A New Frontier in Diagnosis and Treatment. | 2021 | Details |
| A42494 | 34383326 | Hepatology | To Be or Not to Be: The Quest for Patatin-Like Phospholipase Domain Containing 3 p.I148M Function. | 2021 | Details |
| A42495 | 34378991 | Am J Physiol Cell Physiol | Nicotinamide N-methyltransferase upregulation via the mTORC1-ATF4 pathway activation contributes to palmitate-induced lipotoxicity in hepatocytes. | 2021 | Details |
| A42496 | 34374110 | Hepatology | Breastfeeding to Prevent NAFLD. | 2021 | Details |
| A42497 | 34373772 | Oxid Med Cell Longev | Corrigendum to "Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease". | 2021 | Details |
| A42498 | 34366254 | Dig Liver Dis | GLP-1 receptor agonists and reduction of liver fat content in NAFLD patients: Just a question of weight loss? | 2021 | Details |
| A42499 | 34365663 | Hepatology | Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH. | 2021 | Details |
| A42500 | 34362163 | J Clin Med | Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy. | 2021 | Details |
| A42501 | 34362095 | J Clin Med | A Model Incorporating Serum Alkaline Phosphatase for Prediction of Liver Fibrosis in Adults with Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42502 | 34358837 | Clin Nutr | Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg? | 2021 | Details |
| A42503 | 34358825 | Clin Nutr | Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern. | 2021 | Details |
| A42504 | 34358714 | Cell Mol Gastroenterol Hepatol | Liver-Specific Deletion of Mouse CTCF Leads to Hepatic Steatosis via Augmented PPARγ Signaling. | 2021 | Details |
| A42505 | 34345273 | Exp Ther Med | Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat. | 2021 | Details |
| A42506 | 34342515 | Viral Immunol | TLR3\TLR7 as Differentially Expressed Markers Among Viral, Nonviral, and Autoimmune Diseases in Egyptian Patients. | 2021 | Details |
| A42507 | 34331809 | Aliment Pharmacol Ther | Editorial: an elastography-based two-step approach to detect NAFLD with compensated advanced chronic liver disease-authors' reply. | 2021 | Details |
| A42508 | 34331807 | Aliment Pharmacol Ther | Editorial: an elastography-based two-step approach to detect NAFLD with compensated advanced chronic liver disease. | 2021 | Details |
| A42509 | 34331682 | Adv Exp Med Biol | Turmeric and Curcumin: From Traditional to Modern Medicine. | 2021 | Details |
| A42510 | 34328294 | Minerva Endocrinol (Torino) | Mediterranean diet and NAFLD: where are we now? | 2021 | Details |
| A42511 | 34328191 | Int J Mol Med | Dysbiosis and liver diseases (Review). | 2021 | Details |
| A42512 | 34324727 | Hepatology | Multidisciplinary Clinic Models: A Paradigm of Care for Management of NAFLD. | 2021 | Details |
| A42513 | 34321426 | J Pediatr Gastroenterol Nutr | Performance Characteristics, Intra- & Inter-Operator Agreement of Transient Elastography in Pediatric NAFLD. | 2022 | Details |
| A42514 | 34321425 | J Pediatr Gastroenterol Nutr | Performance Characteristics, Intra- and Inter-Operator Agreement of Transient Elastography in Pediatric Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A42515 | 34313620 | Am J Gastroenterol | Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. | 2021 | Details |
| A42516 | 34311112 | Clin Gastroenterol Hepatol | COVID-19 Morbidity and Severity in Patients With Nonalcoholic Fatty Liver Disease in South Korea: A Nationwide Cohort Study. | 2021 | Details |
| A42517 | 34309877 | Hepatology | Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications. | 2021 | Details |
| A42518 | 34305616 | Front Pharmacol | Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. | 2021 | Details |
| A42519 | 34292103 | Crit Rev Food Sci Nutr | Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review. | 2021 | Details |
| A42521 | 34278437 | Int J Mol Med | Role of the S100 protein family in liver disease (Review). | 2021 | Details |
| A42522 | 34278171 | Hepatol Commun | Hepatic Steatosis and Ectopic Fat Are Associated With Differences in Subcutaneous Adipose Tissue Gene Expression in People With HIV. | 2021 | Details |
| A42523 | 34276183 | Ann Gastroenterol | Recent advances in the surgical management of hepatocellular carcinoma. | 2021 | Details |
| A42524 | 34274368 | J Hepatol | Reply to: "Ceruloplasmin variants might have different effects in different iron overload disorders". | 2021 | Details |
| A42525 | 34271111 | J Ethnopharmacol | Antiobesity, hepatoprotective and anti-hyperglycemic effects of a pharmaceutical formulation containing Cecropia pachystachya Trécul in mice fed with a hypercaloric diet. | 2021 | Details |
| A42526 | 34261897 | Curr Opin Pediatr | Managing abnormal liver tests in children with inflammatory bowel disease. | 2021 | Details |
| A42527 | 34253858 | Cell Mol Immunol | Mitochondrial-triggered immune responses mechanistically connect drug-induced steatohepatitis and cardiomyopathy associated with nonalcoholic steatohepatitis. | 2021 | Details |
| A42528 | 34239349 | Int J Biol Sci | Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1. | 2021 | Details |
| A42529 | 34239266 | World J Gastroenterol | Neuropilin-1: A feasible link between liver pathologies and COVID-19. | 2021 | Details |
| A42530 | 34233105 | N Engl J Med | Semaglutide or Placebo for Nonalcoholic Steatohepatitis. Reply. | 2021 | Details |
| A42531 | 34233104 | N Engl J Med | Semaglutide or Placebo for Nonalcoholic Steatohepatitis. | 2021 | Details |
| A42532 | 34233030 | Hepatology | Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD. | 2021 | Details |
| A42533 | 34231523 | Eur J Gastroenterol Hepatol | Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease-sodium alone to predict mortality and liver transplantation. | 2021 | Details |
| A42534 | 34229990 | Mol Metab | NAFLD - A rising metabolic disease. | 2021 | Details |
| A42535 | 34229256 | Clin Nutr | Errors in meta-analysis should be corrected in "Critical appraisal for low-carbohydrate diet in non-alcoholic fatty liver disease: Review and meta-analyses". | 2021 | Details |
| A42536 | 34228993 | J Hepatol | Multiple investigations for a very common disorder: Finding the right balance in NAFLD. | 2021 | Details |
| A42537 | 34221921 | J Clin Transl Hepatol | Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses. | 2021 | Details |
| A42538 | 34220702 | Front Endocrinol (Lausanne) | Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? | 2021 | Details |
| A42539 | 34207318 | Int J Mol Sci | Aberrations in Lipid Expression and Metabolism in Psoriasis. | 2021 | Details |
| A42540 | 34202146 | Biomolecules | Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions. | 2021 | Details |
| A42541 | 34195761 | Ann Acad Med Singap | Non-alcoholic fatty liver disease is associated with subclinical coronary artery disease in otherwise healthy individuals. | 2021 | Details |
| A42542 | 34193189 | Nutr Metab (Lond) | Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF/MS. | 2021 | Details |
| A42544 | 34192127 | GE Port J Gastroenterol | Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. | 2021 | Details |
| A42545 | 34189799 | J Magn Reson Imaging | Editorial for "Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort". | 2021 | Details |
| A42546 | 34185307 | Eat Weight Disord | Reply to letter: "RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study". | 2021 | Details |
| A42547 | 34185279 | Front Med | Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial. | 2021 | Details |
| A42548 | 34183378 | Drug Metab Dispos | Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42549 | 34179194 | Iran J Biotechnol | Co-expression Network Analysis Reveals Key Genes Related to Ankylosing spondylitis Arthritis Disease: Computational and Experimental Validation. | 2021 | Details |
| A42550 | 34175461 | Clin Gastroenterol Hepatol | The Weighty Issue of Treating Obesity in Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42551 | 34175460 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease for the Incidence of Drug-Induced Liver Injury. | 2021 | Details |
| A42552 | 34173916 | Dig Dis Sci | Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults. | 2021 | Details |
| A42553 | 34172646 | Transplantation | Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. | 2022 | Details |
| A42554 | 34170539 | Aliment Pharmacol Ther | Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. | 2021 | Details |
| A42555 | 34170537 | Aliment Pharmacol Ther | Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing. | 2021 | Details |
| A42556 | 34165872 | Liver Transpl | Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival. | 2021 | Details |
| A42557 | 34165698 | Eat Weight Disord | RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity-an observational study. | 2021 | Details |
| A42558 | 34164841 | Hepatology | NAFLD and HCC: Time to Bridge the Gap. | 2021 | Details |
| A42559 | 34163039 | Nat Rev Endocrinol | Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus. | 2021 | Details |
| A42560 | 34162770 | Biomol Ther (Seoul) | Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. | 2021 | Details |
| A42561 | 34161617 | Hepatology | Saroglitazar for the Treatment of NASH: The Peroxisome Proliferator-Activated Receptor Story Goes On! | 2021 | Details |
| A42562 | 34159171 | Hepatobiliary Surg Nutr | Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need. | 2021 | Details |
| A42563 | 34155175 | J Chin Med Assoc | Nonalcoholic fatty liver disease and hepatocellular carcinoma: Distinct links. | 2021 | Details |
| A42564 | 34154309 | Clin Mol Hepatol | KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. | 2021 | Details |
| A42565 | 34153397 | J Hepatol | MAFLD supported by 95.45% participants of CSH is NOT representative. | 2021 | Details |
| A42566 | 34153303 | Metabolism | Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis. | 2021 | Details |
| A42567 | 34152694 | Liver Int | The new multidisciplinary paradigm for fatty liver disease should also include the laboratory medicine contribution. | 2021 | Details |
| A42568 | 34146880 | Chemosphere | Hepatotoxicity in carp (Cyprinus carpio) exposed to environmental levels of norfloxacin (NOR): Some latest evidences from transcriptomics analysis, biochemical parameters and histopathological changes. | 2021 | Details |
| A42569 | 34143330 | Hepatol Int | The clinical and economic burden of non-alcoholic steatohepatitis in the Middle East: behind the scene. | 2021 | Details |
| A42570 | 34142663 | Clin Transl Gastroenterol | Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders. | 2021 | Details |
| A42571 | 34142426 | Diabetes Obes Metab | Sodium-glucose cotransporter-2 inhibitors for type 2 diabetes mellitus in adults: An overview of 46 systematic reviews. | 2021 | Details |
| A42572 | 34139785 | Semin Liver Dis | Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. | 2021 | Details |
| A42573 | 34134003 | Clin Nutr | Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A42574 | 34133256 | Expert Rev Mol Diagn | Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review. | 2021 | Details |
| A42575 | 34131614 | Environ Epidemiol | Prenatal and childhood exposure to air pollution and traffic and the risk of liver injury in European children. | 2021 | Details |
| A42576 | 34127524 | Gut | Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A42577 | 34125228 | J Clin Endocrinol Metab | Endocrine Dysfunction in Patients With Myotonic Dystrophy. | 2021 | Details |
| A42578 | 34119640 | Clin Gastroenterol Hepatol | Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis. | 2021 | Details |
| A42579 | 34118578 | J Nutr Biochem | Corrigendum to 'The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet' [Journal of Nutritional Biochemistry 77 (2020) 108319]. | 2021 | Details |
| A42580 | 34116080 | J Hepatol | Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era? | 2021 | Details |
| A42581 | 34115994 | Cell Mol Gastroenterol Hepatol | Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better. | 2021 | Details |
| A42582 | 34114549 | Dtsch Arztebl Int | Possible Mechanisms: Hyperinsulinemia and Endocrine Disrupting Chemicals. | 2021 | Details |
| A42583 | 34112983 | Nat Rev Endocrinol | Hepatic T helper 17 cells implicated in NAFLD. | 2021 | Details |
| A42584 | 34112767 | Signal Transduct Target Ther | The paradox of immunotherapy in NASH-HCC. | 2021 | Details |
| A42585 | 34108096 | Dig Liver Dis | MAFLD vs NAFLD: Where are we? | 2021 | Details |
| A42586 | 34105827 | J Gastroenterol Hepatol | Liver-heart connection in diabetes mellitus. | 2021 | Details |
| A42587 | 34103708 | Nat Rev Gastroenterol Hepatol | Molecular landscape of NASH-HCC. | 2021 | Details |
| A42588 | 34101669 | Am J Gastroenterol | "Sickeningly Sweet"…. High-Fructose Corn Syrup-Caveat Emptor! | 2021 | Details |
| A42589 | 34097226 | Int J Comput Assist Radiol Surg | Liver disease classification from ultrasound using multi-scale CNN. | 2021 | Details |